26.02.2013 10:05 Uhr, Quelle: Wallstreet online

Antisense Pharma unveils its corporate strategy for 2013

Antisense Pharma GmbH / Antisense Pharma unveils its corporate strategy for 2013 . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Trabedersen clinical development program …

Weiterlesen bei Wallstreet online